$1.45 - PRLD | Prelude Therapeutics Incorporated

Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Incorporated

XNAS:PRLD

1.45

-5.84%

Ask

$6.50 - 2,000.00

Bid

$1.43 - 100.00

Low

$1.43

High

$1.56

Open

$1.56

Prev Close

$1.54

52W High

4.22

52W Low

0.61

Volume

291423

Avg Vol (3m)

405900.7

Float

29840649.14

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 09/25/2020

Primary Exchange: XNAS

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Phone: (302) 467-1280

Address: 175 Innovation Boulevard

City: Wilmington

State: DE

Postal Code: 19805

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

131

P/E (TTM)

-0.900000

P/B (TTM)

1.411770

EPS

-0.26

Round Lot

100

Composit FIGI

BBG00K7JY2Q6

Share Class FIGI

BBG00K7JY2R5

Share Class Shares Outstanding

56.60M

Weighted Shares Outstanding

56.60M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion